Celltrion said on the 24th that it received additional approval from the Ministery of Food and Drug Safety for the auto-injector (AI) formulation of the allergy disease treatment "OMLYCLO." The ...
The Furoscix on-body infusor. [Image courtesy of MannKind] MannKind (Nasdaq:MNKD) announced today that the FDA approved its Furoscix (furosemide) on-body infusor for pediatric patients. The company ...
Health insurance companies love to save money. Who doesn’t? But the calculations for what’s cheapest don’t always look the way you’d expect. Insurers will sometimes choose to cover a significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback